Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemotherapy vs Observation in High-Risk Stage II Colon Cancer with High-Immunoscore
NCT04303429Phase 3Unknown
- Sponsor
- Shanghai General Hospital
- Start
- Aug 2020
- Primary completion
- Jan 2022
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, Orthosteric Ligands
01
Overview
A Phase 3 trial of fluorouracil, folinic acid, oxaliplatin, capecitabine in colon cancer, sponsored by Shanghai General Hospital. Status: unknown.
02
Drugs
fluorouracilfolinic acidoxaliplatincapecitabine
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT04303429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04303429.